FDA Plans To Tap EHR Data To Determine Drug Safety
FDA has announced plans to leverage electronic health records to better evaluate the safety of some drugs. As part of the initiative, the agency is seeking a partner to develop a database of de-identified EHR information. The database would include the EHRs of at least 10 million U.S. residents.
- "FDA Wants To Leverage Electronic Medical Records To Probe For Adverse Events" (Gaffney, Regulatory Focus, 1/6).